The Role of Antibiotic Resistant <i>A. baumannii</i> in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy

• Main Authors: Natalia Bagińska, Martyna Cieślik, Andrzej Górski, Ewa Jończyk-Matysiak
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Antibiotics
• Subjects: bacteriophages; multidrug resistance (MDR); urinary tract infection (UTI); uropatogenic bacteria; critical priority group
• Online Access: https://www.mdpi.com/2079-6382/10/3/281

<i>Acinetobacter baumannii</i> are bacteria that belong to the critical priority group due to their carbapenems and third generation cephalosporins resistance, which are last-chance antibiotics. The growing multi-drug resistance and the ability of these bacteria to form biofilms makes it difficult to treat infections caused by this species, which often affects people with immunodeficiency or intensive care unit patients. In addition, most of the infections are associated with catheterization of patients. These bacteria are causative agents, inter alia, of urinary tract infections (UTI) which can cause serious medical and social problems, because of treatment difficulties as well as the possibility of recurrence and thus severely decrease patients’ quality of life. Therefore, a promising alternative to standard antibiotic therapy can be bacteriophage therapy, which will generate lower costs and will be safer for the treated patients and has real potential to be much more effective. The aim of the review is to outline the important role of drug-resistant <i>A. baumannii</i> in the pathogenesis of UTI and highlight the potential for fighting these infections with bacteriophage therapy. Further studies on the use of bacteriophages in the treatment of UTIs in animal models may lead to the use of bacteriophage therapy in human urinary tract infections caused by <i>A. baumannii</i> in the future.